J Clin Oncol2023 Sep 10.
上皮成長因子受容体エクソン20挿入を有する非小細胞肺癌患者におけるジパレルチニブの安全性、忍容性および抗腫瘍活性
Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions.
Piotrowska Z, Tan DS, Smit EF, Spira AI, Soo RA, Nguyen D, Lee VH, Yang JC, Velcheti V, Wrangle JM, Socinski MA, Koczywas M, Janik JE, Jones J, Yu HA